Comparative effectiveness of minimally invasive versus open lymphadenectomy in urological cancers

Current Opinion in Urology

Volumn 23, Issue 1, 2013, Pages 57-64

  Prasad, Sandip M ^a   Shalhav, Arieh L ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

comparative effectiveness; lymph node dissection; lymphadenectomy; urologic oncology

Indexed keywords

BLADDER CANCER; CANCER PATIENT; CYSTECTOMY; HUMAN; INGUINAL LYMPH NODE; INTERMETHOD COMPARISON; KIDNEY CANCER; KIDNEY CARCINOMA; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MINIMALLY INVASIVE SURGERY; NEPHROURETERECTOMY; PARAAORTIC LYMPH NODE; PATIENT SAFETY; PENIS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; ROBOTICS; SURGICAL APPROACH; SURGICAL TECHNIQUE; TESTIS CANCER; TREATMENT OUTCOME; URINARY TRACT CANCER;

FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; MALE; PROSTATIC NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; UROLOGIC NEOPLASMS;

EID: 84871253952     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32835af286     Document Type: Review

References (98)

1. Herr HW. Surgical factors in bladder cancer: More (nodes) more (pathology) less (mortality). BJU Int 2003; 92:187-188. (Pubitemid 36966574)
2. Schuessler WW, Vancaillie TG, Reich H, Griffith DP. Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J Urol 1991; 145:988-991.
3. Lu-Yao GL, Albertsen PC, Moore DF, et al. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302:1202-1209.
4. Ung JO, Richie JP, Chen MH, et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 2002; 60:458-463. (Pubitemid 35292173)
5. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009; 55:1251-1265.
6. Feifer AH, Elkin EB, Lowrance WT, et al. Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 2011; 117:3933-3942.
7. Prasad SM, Keating NL, Wang Q, et al. Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy. Urology 2008; 72:647-652; discussion 52-53.
8. Hu JC, Prasad SM, Gu X, et al. Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men. Urology 2011; 77:402-406.
9. Guazzoni G, Cestari A, Naspro R, et al. Intra- and peri-operative outcomes comparing radical retropubic and laparoscopic radical prostatectomy: Results from a prospective, randomised, single-surgeon study. Eur Urol 2006; 50:98-104. (Pubitemid 43870132)
10. Asimakopoulos AD, Pereira Fraga CT, Annino F, et al. Randomized comparison between laparoscopic and robot-assisted nerve-sparing radical prostatectomy. J Sex Med 2011; 8:1503-1512.
11. Kang DC, Hardee MJ, Fesperman SF, et al. Low quality of evidence for robotassisted laparoscopic prostatectomy: Results of a systematic review of the published literature. Eur Urol 2010; 57:930-937.
12. Guazzoni G, Montorsi F, Bergamaschi F, et al. Open surgical revision of laparoscopic pelvic lymphadenectomy for staging of prostate cancer: The impact of laparoscopic learning curve. J Urol 1994; 151:930-933. (Pubitemid 24083463)
13. van der Poel HG, De Blok W, Tillier C, Van Muilekom E. Robot assisted laparoscopic prostatectomy (RALP): Nodal dissection results during the first 440 cases in 2 surgeons. J Endourol 2012. [Epub ahead of print]
14. Zorn KC, Katz MH, Bernstein A, et al. Pelvic lymphadenectomy during robotassisted radical prostatectomy: Assessing nodal yield, perioperative outcomes, and complications. Urology 2009; 74:296-302.
15. Eden CG, Arora A, Rouse P. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer. BJU Int 2010; 106:537-542.
16. Wyler SF, Sulser T, Seifert HH, et al. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer. Urology 2006; 68:883-887. (Pubitemid 44633375)
17. Abaza R, Dangle PP, Gong MC, et al. Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended template. J Urol 2012; 187:1200-1204.
18. Mohler J, Bahnson RR, Boston B, et al. NCCN clinical practice guidelines in oncology: Prostate cancer. J Natl Compr Canc Netw 2010; 8:162-200.
19. Abdollah F, Sun M, Suardi N, et al. National comprehensive cancer network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer. J Urol 2012; 188: 423-428.
20. Jayram G, Decastro GJ, Large MC, et al. Robotic radical prostatectomy in patients with high-risk disease: A review of short-term outcomes from a highvolume center. J Endourol 2011; 25:455-457.
21. Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002; 168:514-518; discussion 8. (Pubitemid 34793284)
22. Joniau S, Van den Bergh L, Lerut E, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2012. [Epub ahead of print]
23. Withrow DR, DeGroot JM, Siemens DR, Groome PA. Therapeutic value of lymph node dissection at radical prostatectomy: A population-based casecohort study. BJU Int 2011; 108:209-216.
24. Eden CG, Zacharakis E, Dundee PE, Hutton AC. Incidence of lymphoceles after robot-assisted pelvic lymph node dissection. BJU Int 2012; 109:E14.
25. Novara G, Ficarra V, Rosen RC, et al. Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol 2012; 62:431-452.
26. Clark T, Parekh DJ, Cookson MS, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003; 169:145-147; discussion 7-8. (Pubitemid 35461573)
27. Lallas CD, Pe ML, Thumar AB, et al. Comparison of lymph node yield in robotassisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy. BJU Int 2011; 107:1136-1140.
28. Davis JW, Shah JB, Achim M. Robot-assisted extended pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP): A video-based illustration of technique, results, and unmet patient selection needs. BJU Int 2011; 108:993-998.
29. Yuh BE, Ruel NH, Mejia R, et al. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Eur Urol 2012; 61:1004-1010.
30. Mullins JK, Hyndman ME, Mettee LZ, Pavlovich CP. Comparison of extraperitoneal and transperitoneal pelvic lymph node dissection during minimally invasive radical prostatectomy. J Endourol 2011; 25:1883-1887.
31. Shah K, Abaza R. Comparison of intraoperative outcomes using the new and old generation da Vinci(R) robot for robot-assisted laparoscopic prostatectomy. BJU Int 2011; 108:1642-1645.
32. Skinner DG. Management of invasive bladder cancer: A meticulous pelvic node dissection can make a difference. J Urol 1982; 128:34-36. (Pubitemid 12048751)
33. Kassouf W, Leibovici D, Munsell MF, et al. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 2006; 176:53-57; discussion 7. (Pubitemid 43815383)
34. Nix J, Smith A, Kurpad R, et al. Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: Perioperative and pathologic results. Eur Urol 2010; 57:196-201.
35. Styn NR, Montgomery JS, Wood DP, et al. Matched comparison of robotic-assisted and open radical cystectomy. Urology 2012; 79:1303-1308.
36. Khan MS, Challacombe B, Elhage O, et al. A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy. Int J Clin Pract 2012; 66:656-662.
37. Richards KA, Hemal AK, Kader AK, Pettus JA. Robot assisted laparoscopic pelvic lymphadenectomy at the time of radical cystectomy rivals that of open surgery: Single institution report. Urology 2010; 76:1400-1404.
38. Gondo T, Yoshioka K, Nakagami Y, et al. Robotic versus open radical cystectomy: Prospective comparison of perioperative and pathologic outcomes in Japan. Jpn J Clin Oncol 2012; 42:625-631.
39. Cha EK, Wiklund NP, Scherr DS. Recent advances in robot-assisted radical cystectomy. Curr Opin Urol 2011; 21:65-70.
40. Chade DC, Laudone VP, Bochner BH, Parra RO. Oncological outcomes after radical cystectomy for bladder cancer: Open versus minimally invasive approaches. J Urol 2010; 183:862-869.
41. Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008; 112:2401-2408.
42. Hellenthal NJ, Hussain A, Andrews PE, et al. Lymphadenectomy at the time of robot-assisted radical cystectomy: Results from the International Robotic Cystectomy Consortium. BJU Int 2011; 107:642-646.
43. Hollenbeck BK, Ye Z, Wong SL, et al. Hospital lymph node counts and survival after radical cystectomy. Cancer 2008; 112:806-812. (Pubitemid 351240574)
44. Hellenthal NJ, Hussain A, Andrews PE, et al. Lymphadenectomy at the time of robot-assisted radical cystectomy: Results from the International Robotic Cystectomy Consortium. BJU Int 2011; 107:642-646.
45. Smith AB, Raynor M, Amling CL, et al. Multiinstitutional analysis of robotic radical cystectomy for bladder cancer: Perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A 2012; 22:17-21.
46. Treiyer A, Saar M, Butow Z, et al. Robotic-assisted laparoscopic radical cystectomy: Surgical and oncological outcomes. Int Braz J Urol 2012; 38:324-329.
47. Desai MM, Berger AK, Brandina RR, et al. Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: Technique and outcomes. Eur Urol 2012; 61:350-355.
48. Richards KA, Kader AK, Otto R, et al. Is Robot-assisted radical cystectomy justified in the elderly? a comparison of robotic versus open radical cystectomy for bladder cancer in elderly -75 years old. J Endourol 2012; 26:1301-1306.
49. Guillotreau J, Miocinovic R, Game X, et al. Outcomes of laparoscopic and robotic radical cystectomy in the elderly patients. Urology 2012; 79:585-590.
50. Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph-node dissection: Final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 2009; 55:28-34.
51. Studer UE, Birkhauser FD. Lymphadenectomy combined with radical nephrectomy: To do or not to do? Eur Urol 2009; 55:35-37.
52. Kates M, Lavery HJ, Brajtbord J, et al. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma. Ann Surg Oncol 2012; 19:2693-2699.
53. Filson CP, Miller DC, Colt JS, et al. Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma. Urol Oncol 2011.
54. Jamal JE, Jarrett TW. The current role of lymph node dissection in the management of renal cell carcinoma. Int J Surg Oncol 2011; 2011: 816926.
55. Capitanio U, Becker F, Blute ML, et al. Lymph node dissection in renal cell carcinoma. Eur Urol 2011; 60:1212-1220.
56. Whitson JM, Harris CR, Reese AC, Meng MV. Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol 2011; 185:1615-1620.
57. Jeon SH, Kwon TG, Rha KH, et al. Comparison of laparoscopic versus open radical nephrectomy for large renal tumors: A retrospective analysis of multicenter results. BJU Int 2011; 107:817-821.
58. Jeong W, Rha KH, Kim HH, et al. Comparison of laparoscopic radical nephrectomy and open radical nephrectomy for pathologic stage T1 and T2 renal cell carcinoma with clear cell histologic features: A multiinstitutional study. Urology 2011; 77:819-824.
59. Abaza R, Lowe G. Feasibility and adequacy of robot-assisted lymphadenectomy for renal-cell carcinoma. J Endourol 2011; 25:1155-1159.
60. Terrone C, Guercio S, De Luca S, et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 2003; 91:37-40.
61. Busby JE, Brown GA, Matin SF. Comparing lymphadenectomy during radical nephroureterectomy: Open versus laparoscopic. Urology 2008; 71:413-416. (Pubitemid 351374710)
62. Chapman TN, Sharma S, Zhang S, et al. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology 2008; 71:287-291. (Pubitemid 351282343)
63. Simmons MN, Kaouk J, Gill IS, Fergany A. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma. Urology 2007; 70:43-46. (Pubitemid 47081117)
64. Rosoff JS, Raman JD, Sosa RE, Del Pizzo JJ. Laparoscopic radical nephrectomy for renal masses 7 centimeters or larger. JSLS 2009; 13: 148-153.
65. Rukstalis DB, Chodak GW. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 1992; 148:1907-1909; discussion 9-10.
66. Davol P, Sumfest J, Rukstalis D. Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 2006; 67:199.
67. Hyams ES, Pierorazio P, Proteek O, et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: A large single institution experience. J Urol 2012; 187:487-492.
68. Abdel-Aziz KF, Anderson JK, Svatek R, et al. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germcell testis tumors. J Endourol 2006; 20:627-631. (Pubitemid 46140983)
69. Rassweiler JJ, Scheitlin W, Heidenreich A, et al. Laparoscopic retroperitoneal lymph node dissection: Does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol 2008; 54:1004-1015.
70. Gardner MW, Roytman TM, Chen C, et al. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: A Washington University update. J Endourol 2011; 25:1753-1757.
71. Underwood W, Kim HL. Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. BJU Int 2012; 109:281-285.
72. Ziaee SA, Tabibi A, Sharifiaghdas F, et al. Laparoscopic retroperitoneal lymph node dissection for stage I nonseminomatous germ cell testis tumors: The first case series in Iran. Urol J 2011; 8:27-30.
73. Williams SB, Lau CS, Josephson DY. Initial series of robot-assisted laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer. Eur Urol 2011; 60:1299-1302.
74. Spermon JR, Witjes JA. Case report: The danger of postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma. J Endourol 2008; 22:1013-1016. (Pubitemid 351693944)
75. Schwartz MJ, Kavoussi LR. Controversial technology: The Chunnel and the laparoscopic retroperitoneal lymph node dissection (RPLND). BJU Int 2010; 106:950-959.
76. Herr HW, Bochner BH, Dalbagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167:1295-1298. (Pubitemid 34132073)
77. Weight CJ, Gettman MT. The emerging role of lymphadenectomy in upper tract urothelial carcinoma. Urol Clin North Am 2011; 38:429-437; v.i.
78. Roscigno M, Shariat SF, Margulis V, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 2009; 181: 2482-2489.
79. Lughezzani G, Jeldres C, Isbarn H, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 2010; 75:118-124.
80. Roscigno M, Brausi M, Heidenreich A, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol 2011; 60:776-783.
81. Roscigno M, Shariat SF, Margulis V, et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: How many lymph nodes should be removed? Eur Urol 2009; 56:512-518.
82. Favaretto RL, Shariat SF, Chade DC, et al. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: Are recurrence and disease-specific survival associated with surgical technique? Eur Urol 2010; 58:645-651.
83. Capitanio U, Shariat SF, Isbarn H, et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: A multiinstitutional analysis of 1249 cases. Eur Urol 2009; 56:1-9.
84. Abe T, Shinohara N, Muranaka M, et al. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: Multiinstitutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur J Surg Oncol 2010; 36:1085-1091.
85. Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial carcinoma: Current treatment and outcomes. Urology 2012; 79:749-756.
86. Simone G, Papalia R, Guaglianone S, et al. Laparoscopic versus open nephroureterectomy: Perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 2009; 56:520-526.
87. Ni S, Tao W, Chen Q, et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: A systematic review and cumulative analysis of comparative studies. Eur Urol 2012; 61:1142-1153.
88. Rai BP, Shelley M, Coles B, et al. Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): A systematic review. BJU Int 2012. [Epub ahead of print]
89. Ariane MM, Colin P, Ouzzane A, et al. Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): Results from a large French multicenter collaborative study. Ann Surg Oncol 2012; 19:301-308.
90. Walton TJ, Novara G, Matsumoto K, et al. Oncological outcomes after laparoscopic and open radical nephroureterectomy: Results from an international cohort. BJU Int 2011; 108:406-412.
91. Hanna N, Sun M, Trinh QD, et al. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: A national series. Eur Urol 2012; 61:715-721.
92. Abe T, Harabayashi T, Shinohara N, et al. Outcome of regional lymph node dissection in conjunction with laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract. J Endourol 2011; 25:803-807.
93. Tobias-MachadoM, Tavares A, SilvaMN, et al. Can video endoscopic inguinal lymphadenectomy achieve a lower morbidity than open lymph node dissection in penile cancer patients? J Endourol 2008; 22:1687-1691.
94. Sotelo R, Sanchez-Salas R, Carmona O, et al. Endoscopic lymphadenectomy for penile carcinoma. J Endourol 2007; 21:364-367; discussion 7. (Pubitemid 46764197)
95. Tobias-Machado M, Tavares A, Ornellas AA, et al. Video endoscopic inguinal lymphadenectomy: A new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. J Urol 2007; 177:953-957; discussion 8.
96. Josephson DY, Jacobsohn KM, Link BA, Wilson TG. Robotic-assisted endoscopic inguinal lymphadenectomy. Urology 2009; 73:167-170; discussion 70-71.
97. Britto CA, Reboucas RB, Lopes TR, et al. Video-assisted left inguinal lymphadenectomy for penile cancer. Int Braz J Urol 2012; 38:289; discussion 90.
98. Dogra PN, Saini AK, Singh P. Robotic-assisted inguinal lymph node dissection: A preliminary report. Indian J Urol 2011; 27:424-427.